Propel Bio Management, LLC / SABS
Propel Bio Management, LLC’s Sab Biotherapeutics Inc Position
Does Propel Bio Management, LLC own Sab Biotherapeutics Inc (SABS)? Yes — 1.01M shares worth $4M (+2.45% of its 13F portfolio) as of Q1 2026, up from 652.9K shares the prior filed quarter.
Position Value
$4M
Q1 2026
Shares
1.01M
% of Portfolio
+2.45%
Quarters Held
2
currently held
Position History SABS
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Propel Bio Management, LLC’s full portfolio or all institutional holders of SABS.